Montelukast
Montelukast Sandoz is a leukotriene receptor antagonist, which inhibits the activity of substances called leukotrienes.
Leukotrienes cause the airways to narrow and swell, and cause allergy symptoms. By inhibiting the activity of leukotrienes, Montelukast Sandoz relieves the symptoms of asthma, helps control it, and relieves the symptoms of seasonal allergies (also known as hay fever or seasonal allergic rhinitis).
Your doctor has prescribed Montelukast Sandoz to treat asthma and prevent its symptoms from occurring during the day and night. Montelukast Sandoz is used in adults and adolescents aged 15 years and older, who have not achieved adequate control of asthma with their current medications and require additional treatment. Montelukast Sandoz also helps prevent narrowing of the airways caused by physical exertion. In patients with asthma, for whom Montelukast Sandoz is indicated, this medicine may also relieve the symptoms of seasonal allergic rhinitis. Your doctor will determine how to use Montelukast Sandoz based on the symptoms and severity of your asthma.
Asthma is a chronic disease. The picture of asthma includes: difficulty breathing due to narrowing of the airways, which worsens and improves in response to various conditions; sensitivity of the airways to a number of factors, such as cigarette smoke, pollen, cold air, or physical exertion; swelling (inflammation) of the mucous membrane lining the airways. The symptoms of asthma include: coughing, wheezing, and chest tightness.
Seasonal allergies (also known as hay fever or seasonal allergic rhinitis) are an allergic reaction to pollen in the air from trees, grasses, and weeds. Typical symptoms of seasonal allergies may include: stuffy nose, runny nose, itchy nose, sneezing, tearing, swelling, redness, and itchy eyes.
Tell your doctor about all diseases or allergies you have now or have had in the past.
If you are allergic to montelukast or any of the other ingredients of this medicine (listed in section 6).
Before taking Montelukast Sandoz, discuss it with your doctor or pharmacist. If your asthma worsens or your breathing gets worse, tell your doctor right away. The oral medicine Montelukast Sandoz is not intended for the treatment of acute asthma attacks. In case of an asthma attack, follow the instructions given by your doctor. Always carry your inhaler with you, which is intended for use in asthma attacks. It is important that you (adult or child) take all asthma medications prescribed by your doctor. Do not replace other asthma medications prescribed by your doctor with Montelukast Sandoz. Every patient taking asthma medications should know that if they experience a set of symptoms such as flu-like symptoms, tingling or numbness of the hands or feet, worsening of respiratory symptoms, and/or rash, they should consult a doctor. Do not take aspirin or other non-steroidal anti-inflammatory drugs (also known as NSAIDs) if they worsen your asthma symptoms.
While taking montelukast, if you experience such symptoms, consult your doctor.
The medicine should not be used in children under 15 years of age. For these patients (in different age categories), Montelukast Sandoz is available in other forms.
Tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as any medicines you plan to take, including those available without a prescription. Some medicines may affect how Montelukast Sandoz works, or vice versa, Montelukast Sandoz may change the effect of other medicines. Before taking Montelukast Sandoz, tell your doctor about taking the following medicines: phenobarbital (used to treat epilepsy), phenytoin (used to treat epilepsy), rifampicin (used to treat tuberculosis and some other infections), gemfibrozil (a medicine used to lower high blood lipid levels).
Montelukast Sandoz can be taken with or without food.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Pregnancy Your doctor will assess whether you can take Montelukast Sandoz during this period. Breastfeeding It is not known whether Montelukast Sandoz passes into breast milk. If you are breastfeeding or plan to breastfeed, consult your doctor before taking Montelukast Sandoz.
Montelukast Sandoz should not affect your ability to drive or use machines, however, the effect of the medicine may vary from person to person. Certain side effects reported during treatment with Montelukast Sandoz, such as dizziness and drowsiness, may affect the ability to drive or use machines in some patients.
If you have been told that you have an intolerance to some sugars, contact your doctor before taking this medicine. This medicine contains less than 1 mmol (23 mg) of sodium per film-coated tablet, which means it is essentially 'sodium-free'.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist. Take only one tablet of Montelukast Sandoz once daily, as recommended by your doctor. Take the medicine even when you have no symptoms and on days when you have an asthma attack.
The recommended dose is one 10 mg tablet to be taken once daily in the evening. If you are taking Montelukast Sandoz, make sure you do not take any other medicine that contains the same active substance - montelukast. Take the medicine by mouth. The medicine can be taken with or without food. Do not take Montelukast Sandoz in children under 15 years of age due to the high content of the active substance. Other forms of the medicine are available for younger children.
Contact your doctor immediately. In most reports of overdose, no adverse effects were reported. The most common adverse effects reported in association with overdose in adults and children were abdominal pain, drowsiness, thirst, headache, vomiting, and hyperactivity.
Try to take Montelukast Sandoz as recommended. If you miss a dose, go back to your normal schedule and take one tablet once daily. Do not take a double dose to make up for a missed tablet.
Montelukast Sandoz is effective in treating asthma only when taken regularly. It is important to take Montelukast Sandoz for as long as your doctor recommends. This will help control your asthma symptoms. If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rareside effects (may affect up to 1 in 100 people): allergic reactions, including swelling of the face, lips, tongue, and/or throat, which may cause difficulty in breathing or swallowing; changes in behavior and mood: agitation, including aggressive behavior or hostility, depression, and seizures. Very rareside effects (may affect up to 1 in 10,000 people): increased risk of bleeding; tremors; palpitations; Very rareside effects (may affect up to 1 in 10,000 people): decreased platelet count (thrombocytopenia); changes in behavior and mood: hallucinations, disorientation, suicidal thoughts and behaviors. Warning signs are, for example, talking about suicide, withdrawal, and wanting to be left alone, or feeling trapped or helpless; yellowing of the skin and eyes, unusual feeling of tiredness or fever, dark urine due to liver inflammation; swelling (inflammation) of the lungs; a set of symptoms such as flu-like symptoms, tingling or numbness of the hands and feet, worsening of respiratory symptoms, and/or rash (Churg-Strauss syndrome). If a child experiences one or more of these symptoms, contact your doctor immediately; severe skin reactions (erythema multiforme), which may occur without warning. The most commonly reported side effects (may affect up to 1 in 10 people) associated with montelukast and reported in clinical trials with the use of 4 mg oral granules, 4 mg or 5 mg chewable tablets, or 10 mg film-coated tablets were: abdominal pain; headache; thirst; diarrhea; hyperactivity; asthma; skin peeling and itching; rash. These side effects were usually mild and occurred more frequently in patients treated with montelukast than in patients receiving placebo (tablets without active substance). In addition, the following side effects have been reported during the post-marketing period: Very commonside effects (may affect more than 1 in 10 people): upper respiratory tract infections; Commonside effects (may affect up to 1 in 10 people): diarrhea, nausea, vomiting; abnormal liver function tests; rash; fever; Uncommonside effects (may affect up to 1 in 100 people): changes in behavior and mood (abnormal dreams, including nightmares, difficulty sleeping, sleepwalking, irritability, feeling anxious, restlessness); dizziness, drowsiness, feeling of tingling or numbness; nosebleeds; dry mouth, indigestion; bruising, itching, hives; joint or muscle pain, muscle cramps; bedwetting in children; feeling tired, unwell, swelling; Rareside effects (may affect up to 1 in 1,000 people): tremors; attention disorders, memory impairment; uncontrolled movements; Very rareside effects (may affect less than 1 in 10,000 people): tender, red lumps under the skin, most commonly on the shins (erythema nodosum); stuttering; obsessive-compulsive symptoms.
If you experience any side effects, including those not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301/fax: +48 22 49 21 309/website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month. Do not store above 30°C. Store in the original package to protect from light and moisture. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is montelukast. Each film-coated tablet contains montelukast sodium, which is equivalent to 10 mg of montelukast. The other ingredients are: Core: lactose monohydrate, hydroxypropylcellulose (type EF), microcrystalline cellulose, sodium croscarmellose, magnesium stearate; Coating: polyvinyl alcohol, titanium dioxide (E 171), macrogol 400, talc, yellow iron oxide (E 172), red iron oxide (E 172).
Beige, round, biconvex film-coated tablets, smooth on both sides. The film-coated tablets are packaged in blisters made of OPA/ALU/PVC/ALU foil and placed in a carton. The packs contain 28, 30, 60, or 90 film-coated tablets.
Marketing authorization holder Sandoz GmbH Biochemiestrasse 10 6250 Kundl, Austria Manufacturer/Importer Salutas Pharma GmbH Otto-von-Guericke-Allee 1 39179 Barleben, Germany Lek S.A. ul. Domaniewska 50 C 02-672 Warsaw Lek Pharmaceuticals d.d. Verovškova 57 1526 Ljubljana, Slovenia Lek Pharmaceuticals d.d. Trimlini 2D 9220 Lendava, Slovenia S.C. Sandoz, S.R.L. Str. Livezeni nr. 7A 540472 Targu-Mures, Romania Lek S.A. ul. Podlipie 16 95-010 Stryków
Sandoz Polska Sp. z o.o. ul. Domaniewska 50 C 02-672 Warsaw tel. 22 209 70 00 Date of last revision of the leaflet:05/2024 Sandoz logo
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.